Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
05/2001
05/22/2001US6235789 Glandular disorders; sleep disorders
05/22/2001US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis
05/22/2001US6235778 Anticoagulants
05/22/2001US6235759 Benign prostatic hyperplasia; hypotensive agents
05/22/2001US6235736 3-anilino-2-cycloalkenone derivatives
05/22/2001US6235732 Neurokinin antagonists
05/22/2001CA2031937C Isomers of 1-azabicyclo¬2.2.2|oct-3-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-nitropyridine-3-carboxylate
05/16/2001EP1099438A2 Use of APO B secretion/MTP inhibitors
05/16/2001EP1098894A1 Fkbp inhibitors
05/16/2001EP1098878A1 Bispiperidines as antithrombotic agents
05/16/2001EP1098870A2 Nitric esters and nitrate salts of specific drugs
05/16/2001EP1098864A1 Method for hydrogenating unsaturated heterocyclic compounds
05/16/2001EP1098651A2 Novel urokinase inhibitors
05/16/2001CN1295563A 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists
05/16/2001CN1295562A Biocidal benzylbiphenyl derivatives
05/16/2001CN1295561A N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres
05/16/2001CN1295558A Novel local anesthetic compounds and uses
05/16/2001CN1295479A Beta 2-adrenergic receptor agonist
05/16/2001CN1295471A Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
05/15/2001US6232469 For dyes, polymers
05/15/2001US6232342 Protease inhibitors
05/15/2001US6232336 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
05/15/2001US6232329 Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles
05/15/2001US6232323 Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same
05/15/2001US6232319 Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them
05/15/2001CA2238978C Retroviral protease inhibiting compounds
05/10/2001WO2001032649A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
05/10/2001CA2387613A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
05/09/2001EP1097924A1 4-hydroxy-4-phenylpiperidine derivatives having -opioid agonist activity and pharmaceuticals containing the same
05/09/2001EP1097137A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists
05/09/2001EP1097134A1 Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers
05/09/2001EP1097117A2 Aryl vinyl ether derivatives and their use as herbicides
05/09/2001EP1096935A1 Medicinal product and method for treatment and prevention of dyskinesia
05/09/2001EP1066035A4 Substituted aromatic compounds for treatment of antibiotic resistant infections
05/09/2001CN1294127A Process for preparing piperine
05/09/2001CN1294121A N-acyl amino-acid amide prodn. process
05/08/2001US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors
05/08/2001US6228853 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/08/2001CA2324330A1 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same
05/08/2001CA2032141C Pharmaceutically active agents that impede amyloid formation in vivo
05/03/2001WO2001030756A1 Benzamidine derivatives
05/03/2001WO2001030752A2 Indole compounds for treating bacterial infections
05/03/2001WO2001010839A3 Multivalent substituted ketoamides and amides for treating hair loss
05/02/2001EP1095939A2 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
05/02/2001EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
05/02/2001EP1095006A1 Derivatives of 1-oxyl-4-hydroxy-or 4-amino-2,2,6,6-tetramethylpiperidine as polymerization inhibitors for (meth) acrylate monomers
05/02/2001EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
05/02/2001EP1094816A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
05/02/2001EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
05/02/2001EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
05/02/2001EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/02/2001CN1293669A Benzylpiperazingl-and benzylipeeridinyl ethanone derivatives, their preparation method and their use as dopamine D receptor antagonists
05/02/2001CN1293666A Benzenesulfonamide-derivatives and their use as medicaments
05/02/2001CN1293193A Preparation of piperidyl amino methyl trifluoro methyl cyclo other compounds
05/01/2001US6225473 Reacting 1-methylpiperidin-4-one hydrobromide with bromine; reacting with 1,3,5-trimethoxybenzene; reacting solid with water to produce 3(r,s)-hydroxy-1-methyl-4-(2,4,6-trimethoxy-phenyl)-1,2,3,6-te
05/01/2001US6225375 Preparation of low-dust stabilizers
05/01/2001US6225351 For therapy of asthma, arthritis, and sepsis bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis, sepsis, septic shock, cachexia, acquire immuno deficiency syndrome (aids)
05/01/2001US6225341 For inhibiting neuraminidase; for therapy and prophylaxis of virus infection
05/01/2001US6225325 Administering n-substituted-1,5-dideoxy-1,5-imino-d-glucitol or galactitol for prophylaxis, therapy, reducing, or reversing multidrug resistance in patient undergoing therapy with chemotherapeutic agent
05/01/2001US6225324 Antidepressant heterocyclic compounds
05/01/2001US6225323 Activated iododerivatives for the treatment of cancer and AIDS
05/01/2001US6225302 Amidino protease inhibitors
05/01/2001CA2022576C Process for the preparation of castanospermine esters
04/2001
04/26/2001WO2001029032A1 Process for the preparation of paroxetine
04/26/2001WO2001029031A1 Process for the preparation of paroxetine
04/26/2001WO2001029002A1 Process for the preparation of 4-(fluorophenyl)piperidine esters
04/26/2001WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/26/2001WO2001002357A3 Process for the synthesis of 4-(4'-fluorophenyl)-piperidines
04/26/2001WO2000071519A3 Immunopotentiator agents
04/26/2001WO2000055125A3 N-cyanomethyl amides as protease inhibitors
04/26/2001US20010000522 Heating the compound in an aqueous medium which includes an organic cosolvent, and recovering the product that is precipitated, on cooling
04/26/2001US20010000511 Treatment of skin disorders, inflammation, nerve system disorders, cancer
04/26/2001DE19950775A1 Production of pethidine hydrohalides, comprises debenzylation of new 4-ethoxycarbonyl-1-benzyl-1-methyl-4-phenyl-piperidine hydrohalide, useful as analgesics
04/26/2001CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity
04/25/2001EP1094059A1 Process for production of N-acyl amino acid amide
04/25/2001EP1093819A2 Compounds and compositions for delivering active agents
04/25/2001EP0994872B1 4-phenylpiperidine compounds
04/25/2001EP0701568B1 New peptide derivatives
04/25/2001CN1292698A Glycine transport inhibitors
04/24/2001US6222034 As serotinin receptor antagonists; for therapy of depression, central nervous system disorders
04/24/2001US6221871 Treating schizophrenia, depression or parkinson's disease
04/24/2001US6221868 Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives
04/24/2001US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase.
04/24/2001CA2222976C Benzoyl piperidines/pyrrolidines for enhancing synaptic response
04/24/2001CA2220055C Dipeptides which promote release of growth hormone
04/24/2001CA2193468C 3-[(5-substituted benzyl)amino]-2-phenylpiperidines as substance p antagonists
04/19/2001WO2001027082A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN αvβ3 ANTAGONISTS
04/19/2001WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
04/19/2001WO2000064423A3 Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
04/19/2001WO2000061125A3 Osanetant in the treatment of mood disorders
04/19/2001CA2386821A1 3-aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists
04/18/2001EP1092713A2 Piperidinopentanamines and their use as catalysts in the preparation of urethanes
04/18/2001EP1091938A2 Antihistaminic piperidine derivatives and intermediates for the preparation thereof
04/18/2001EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
04/18/2001EP1091737A2 Calcium channel blockers
04/18/2001CN1292034A Method for enzymatic enantiomer-separation of 3(R)-and 3(S)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridine or its carboxylic acid esters
04/18/2001CN1291984A Glycine transport inhibitors
04/18/2001CN1291977A Amino anthracyclinone derivatives and their use in treatment of amyloidosis
04/18/2001CN1291653A Piperidine derivative, its preparation method and application
04/17/2001US6218542 Synthesis of cisapride